Investors Purchase Large Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 1,885 put options on the stock. This is an increase of approximately 1,101% compared to the average volume of 157 put options.

Evelo Biosciences Price Performance

Evelo Biosciences has a 1 year low of $0.00 and a 1 year high of $5.27. The stock has a 50-day moving average of $0.03 and a two-hundred day moving average of $0.04. The stock has a market capitalization of $2,000.00, a price-to-earnings ratio of 0.00 and a beta of 1.59.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.